The combined solutions are currently available on the market.
TrakCel announced on March 17, 2023 that their collaboration with Lonza has reached a new milestone, resulting in a secure, reliable combination of TrakCel’s cell orchestration platform OCELLOS and Lonza’s manufacturing MODA-ES(R) platform. This integration will translate into critical manufacturing steps, checks, and data flow directly into the Chain of Custody and Chain of Identity within the cell and gene therapy supply chain without the opportunity of being missed or not connecting with the patient journey.
For developers, this will assist in them gaining additional visibility and control while reducing product loss, delayed treatment, recalls, and poor-quality product. The combined solutions are currently available on the market.
The collaboration between TrakCel and Lonza includes a multi-phase rollout of connectivity with OCELLOS to other Lonza systems like SAP and LIMs. Other integrations are planned to follow the MES proof of concept and are likely to be completed in the second half of 2023.
Source: TrakCel
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Intertek to Expand UK GMP Facility with 6000 Square Feet of Lab and Office Space
May 7th 2025The company said the expansion is in response to globally rising demand for inhaled biologics, which offer distinct advantages in route of administration, but can be challenging products for developers.